Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mossad SB"" wg kryterium: Autor


Tytuł:
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization
Autorzy:
Avery, RK
Pohlman, BLAff2, Aff3
Mossad, SB
Goormastic, M
Longworth, DL
Kalaycio, MEAff2, Aff3
Sobecks, RMAff2, Aff3
Andresen, SWAff2, Aff3
Kuczkowski, E
Bernhard, L
Ostendorf, H
Wise, K
Bolwell, BJAff2, Aff3
Pokaż więcej
Źródło:
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 30(5):311-314
Czasopismo naukowe
Tytuł:
Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation
Autorzy:
Mossad, SB
Avery, RKAff1, Aff2
Longworth, DL
Kuczkowski, EM
McBee, M
Pohlman, BL
Sobecks, RM
Kalaycio, ME
Andresen, SW
Macklis, RM
Bolwell, BJ
Pokaż więcej
Źródło:
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 28(5):491-495
Czasopismo naukowe
Tytuł:
A randomized trial of single daily dose vancomycin and tobramycin plus oral ciprofloxacin versus standard-dose vancomycin, ceftazidime, and tobramycin in febrile neutropenic recipients of autologous peripheral blood progenitor cell transplants.
Autorzy:
Avery K
Goldman MP
Pohlman B
Longworth DL
Mendez Z
Lauer MS
Mason P
Mossad SB
Adal KA
Schmitt SK
Kalaycio M
Andresen S
Krivoy ME
Brakeman J
Bolwell B
Pokaż więcej
Źródło:
Journal of Infectious Disease Pharmacotherapy; 2002, Vol. 5 Issue 3, p9-20, 12p
Czasopismo naukowe
Tytuł:
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Autorzy:
Ariza-Heredia EJ; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Winston DJ; Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
Rowley SD; Hackensack University Medical Center, Hackensack, New Jersey, USA.
Mullane K; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Chandrasekar P; Division of Infectious Diseases, Department of Medicine, Karmanos Cancer Center, Wayne State University, Detroit, Michigan, USA.
Hari P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Avery RK; Division of Infectious Diseases (Transplant Oncology), Johns Hopkins University, Baltimore, Maryland, USA.
Peggs KS; Department of Haematology, University College London Cancer Institute and University College London Hospitals National Health Service Foundation Trust, London, UK.
Kumar D; Transplant Infectious Diseases, University Health Network, Toronto, Canada.
Nath R; Bone Marrow Transplant, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.
Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge, and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Mossad SB; Department of Infectious Diseases, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
El Haddad L; Department of Medicine, University of Florida, Gainesville, Florida, USA.
Shah DP; Department of Population Health Sciences, Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, Texas, USA.
Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Khawaja F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dadwal S; Division of Infectious Diseases, City of Hope, Duarte, California, USA.
Blanchard T; Oxford Immunotec USA, Marlborough, Massachusetts, USA.
Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Jul 22; Vol. 10 (8), pp. ofad386. Date of Electronic Publication: 2023 Jul 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Pre-transplant vaccination compliance in adult heart and lung transplant recipients.
Autorzy:
Neuhaus KA; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Mossad SB; Department of Infectious Diseases, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Pallotta A; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Srinivas P; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
West L; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Budev MM; Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Rivard K; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2021 Nov; Vol. 35 (11), pp. e14464. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Transplant Recipients*
Adult ; Humans ; Lung ; Retrospective Studies ; Vaccination
Czasopismo naukowe
Tytuł:
Secular trends of Blood stream infections in allogeneic hematopoietic cell transplant recipients 72 hours prior to death.
Autorzy:
Mani S; Department of Hematology Oncology, Adena Cancer Center, Chillicothe, OH, USA.
Aleixo GFP; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
Rybicki L; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Majhail NS; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
Mossad SB; Department of Infectious Diseases, Respiratory Institute Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Aug; Vol. 23 (4), pp. e13631. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
Bacteremia*/drug therapy
Bacteremia*/epidemiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Vancomycin-Resistant Enterococci*
Anti-Bacterial Agents/therapeutic use ; Humans ; Retrospective Studies ; Transplant Recipients
Czasopismo naukowe
Tytuł:
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents.
Autorzy:
Miller MA; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Denver, Colorado, USA.
Molina KC; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Denver, Colorado, USA.
Gutman JA; Division of Hematology and Oncology, University of Colorado Denver, Denver, Colorado, USA.
Scherger S; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
Lum JM; Department of Infectious Diseases, Respiratory Institute and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Mossad SB; Department of Infectious Diseases, Respiratory Institute and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Burgess M; Division of Infectious Diseases, University of Arkansas, Fayetteville, Arkansas, USA.
Cheng MP; Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.; Division of Medical Microbiology, McGill University Health Centre, Montreal, Canada.
Chuang ST; Division of Infectious Diseases, University of Rochester, Rochester, New York, USA.
Jacobs SE; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Melendez DP; Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
Shah DP; Division of Infectious Diseases, University of San Antonio, San Antonio, Texas, USA.
Zimmer A; Division of Infectious Diseases, University of Nebraska, Lincoln, Nebraska, USA.
Sohail MR; Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
Syed S; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Walker RC; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Poeschla EM; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
Abidi MZ; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 30; Vol. 8 (2), pp. ofaa646. Date of Electronic Publication: 2020 Dec 30 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Autorzy:
Modi A; Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, USA.
Rybicki L; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Majhail NS; Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, USA.
Mossad SB; Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Feb; Vol. 22 (1), pp. e13217. Date of Electronic Publication: 2019 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Bacteremia/*complications
Graft vs Host Disease/*complications
Hematopoietic Stem Cell Transplantation/*adverse effects
Transplantation, Homologous/*adverse effects
Acute Disease ; Adolescent ; Adult ; Aged ; Female ; Graft vs Host Disease/microbiology ; Humans ; Incidence ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma.
Autorzy:
Rahman S; Department of Internal Medicine, Cleveland Clinic, Fairview Hospital, Cleveland, Ohio.
Rybicki L; Department of Qualitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Ky Hamilton B; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Pohlman B; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Jagadeesh D; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Cober E; Department of Infectious Diseases, Section of Transplant Infectious Diseases and Transplant Center, Cleveland Clinic, Cleveland, Ohio.
Kalaycio M; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Dean R; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Sobecks R; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Mossad SB; Department of Infectious Diseases, Section of Transplant Infectious Diseases and Transplant Center, Cleveland Clinic, Cleveland, Ohio.
Majhail NS; Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2019 Aug; Vol. 21 (4), pp. e13114. Date of Electronic Publication: 2019 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*adverse effects
Multiple Myeloma/*complications
Multiple Myeloma/*microbiology
Adult ; Age Factors ; Aged ; Bacterial Infections/complications ; Clostridium Infections/complications ; Disease-Free Survival ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Multiple Myeloma/mortality ; Mycoses/complications ; Neoplasm Recurrence, Local ; Retrospective Studies ; Risk Factors ; Transplantation, Autologous/adverse effects ; Virus Diseases/complications ; Young Adult
Czasopismo naukowe
Tytuł:
Training in transplant infectious diseases: A survey of infectious diseases and transplant infectious diseases fellows in the United States and Canada.
Autorzy:
Tan SK; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Theodoropoulos N; Division of Infectious Diseases & Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mossad SB; Department of Infectious Diseases, Respiratory Institute and Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Kotton CN; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Danziger-Isakov LA; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Kumar D; Transplant Infectious Diseases, University Health Network, Toronto, ON, Canada.
Huprikar S; Division of Infectious Diseases, The Mount Sinai Hospital, New York, NY, USA.
Pokaż więcej
Corporate Authors:
American Society of Transplantation, Infectious Diseases Community of Practice
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2018 Aug; Vol. 20 (4), pp. e12915. Date of Electronic Publication: 2018 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
Communicable Diseases/*therapy
Hematopoietic Stem Cell Transplantation/*adverse effects
Internship and Residency/*methods
Organ Transplantation/*adverse effects
Canada ; Communicable Diseases/diagnosis ; Communicable Diseases/immunology ; Curriculum ; Fellowships and Scholarships ; Humans ; Internship and Residency/statistics & numerical data ; Mobile Applications/statistics & numerical data ; Personal Satisfaction ; Practice Guidelines as Topic ; Surveys and Questionnaires ; United States
Czasopismo naukowe
Tytuł:
Epidemiology and risk factors for infections in myelodysplastic syndromes.
Autorzy:
Sullivan LR; Department of Infectious Disease, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sekeres MA
Shrestha NK
Maciejewski JP
Tiu RV
Butler R
Mossad SB
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2013 Dec; Vol. 15 (6), pp. 652-7. Date of Electronic Publication: 2013 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Neutrophils*
Infections/*epidemiology
Myelodysplastic Syndromes/*epidemiology
Autoimmune Diseases/epidemiology ; Case-Control Studies ; Disease Progression ; Female ; Hospitalization ; Humans ; Leukocyte Count ; Male ; Myelodysplastic Syndromes/blood ; Neoplasms/epidemiology ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Risk Factors
Czasopismo naukowe
Tytuł:
Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
Autorzy:
Cuellar-Rodriguez J; Department of Infectious Disease, Medicine Institute, Cleveland, OH, USA.
Stephany B
Poggio E
Mossad SB
Goldfarb D
Lard M
Askar M
Fatica R
Srinivas T
Braun W
Shoskes D
Flechner S
Schmitt SK
Shrestha R
Avery RK
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2013 May-Jun; Vol. 27 (3), pp. E230-6. Date of Electronic Publication: 2013 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Kidney Transplantation*
BK Virus/*drug effects
DNA, Viral/*blood
Isoxazoles/*therapeutic use
Polyomavirus Infections/*immunology
Tumor Virus Infections/*immunology
Viral Load/*immunology
BK Virus/immunology ; Female ; Graft Rejection/immunology ; Humans ; Immunosuppressive Agents/therapeutic use ; Leflunomide ; Male ; Polyomavirus Infections/drug therapy ; Polyomavirus Infections/virology ; Tumor Virus Infections/drug therapy ; Tumor Virus Infections/virology ; Viremia/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies